Records containing: Hemophagocytic Syndrome
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-11-20The Formation of a Cohort of HLHa Patients in Order to Study Their Physiopathological Characteristics
-
CLINICAL_TRIALS study record update · 2025-07-11Administration of Haploidentical Donor T Cells Transduced With the Inducible Caspase-9 Suicide Gene
-
CLINICAL_TRIALS study record update · 2025-05-13A Prospective Study to Validate the Prognostic Power of the Optimized HLH Inflammatory (OHI) Index
-
CLINICAL_TRIALS study record update · 2024-10-01Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis: a Multi-center, Prospective Study
-
CLINICAL_TRIALS study record update · 2023-08-30A Randomized Controlled Study of High-dose Cyclophosphamide Induction Therapy in Adult Patients With HLH
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-04-29Phase I, Single-center, Randomized, Double-blind, Single-dose, Parallel Comparison of Pharmacokinetic and Safety Similarities Between Meperizumab Injection and NUCALA® in Healthy Male Volunteers
-
CLINICAL_TRIALS study record update · 2021-08-11A Prospective Clinical Study of Ruxolitinib Phosphate Tablets and Etoposide Combined With DDGP Regimen (RUE-DDGP) in Induction Therapy of T/NK Cell Lymphoma-associated Hemophagocytic Syndrome.
-
CLINICAL_TRIALS study record update · 2020-08-05A Single-center, Open-label, Controlled Clinical Study to Evaluate the Efficacy and Safety of Jinyouli®(PEG-rhG-CSF) for the Recovery of Neutropenia After Chemotherapy in Patients With Hemophagocytic Syndrome